Steven Valiquette
Stock Analyst at Mizuho
(3.61)
# 940
Out of 5,042 analysts
114
Total ratings
61.67%
Success rate
3.61%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COR Cencora | Maintains: Outperform | $316 → $334 | $332.71 | +0.39% | 1 | Oct 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $210 → $170 | $135.21 | +25.73% | 12 | Oct 13, 2025 | |
| MCK McKesson | Maintains: Neutral | $750 → $770 | $801.67 | -3.95% | 4 | Sep 24, 2025 | |
| VEEV Veeva Systems | Maintains: Outperform | $295 → $325 | $293.02 | +10.91% | 4 | Aug 29, 2025 | |
| PHR Phreesia | Initiates: Outperform | $36 | $23.48 | +53.32% | 1 | Aug 27, 2025 | |
| NVST Envista Holdings | Maintains: Underperform | $15 → $18 | $20.36 | -11.59% | 2 | Aug 1, 2025 | |
| TDOC Teladoc Health | Initiates: Neutral | $10 | $9.46 | +5.71% | 1 | Jul 25, 2025 | |
| WAY Waystar Holding | Initiates: Outperform | $48 | $38.97 | +23.17% | 1 | Jun 30, 2025 | |
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $66.84 | -10.23% | 3 | May 16, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $161.89 | -7.34% | 6 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $21 → $18 | $13.11 | +37.30% | 7 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $70 → $82 | $71.44 | +14.78% | 2 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $7 | $6.30 | +11.11% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $126 | $96.50 | +30.57% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $75 | $63.84 | +17.48% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.76 | +81.16% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $5.51 | +154.08% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $210.68 | -32.60% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $70.39 | -21.86% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $177.94 | -48.30% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $362.50 | +55.86% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $81.93 | +22.06% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $5.13 | +172.90% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $163.32 | +144.92% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $34.07 | +214.06% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $35.17 | -51.66% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $8.83 | +35.90% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $126.13 | -23.89% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $182.18 | -34.13% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $447.04 | -71.59% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $290.65 | +23.17% | 3 | Dec 6, 2019 |
Cencora
Oct 16, 2025
Maintains: Outperform
Price Target: $316 → $334
Current: $332.71
Upside: +0.39%
Align Technology
Oct 13, 2025
Maintains: Outperform
Price Target: $210 → $170
Current: $135.21
Upside: +25.73%
McKesson
Sep 24, 2025
Maintains: Neutral
Price Target: $750 → $770
Current: $801.67
Upside: -3.95%
Veeva Systems
Aug 29, 2025
Maintains: Outperform
Price Target: $295 → $325
Current: $293.02
Upside: +10.91%
Phreesia
Aug 27, 2025
Initiates: Outperform
Price Target: $36
Current: $23.48
Upside: +53.32%
Envista Holdings
Aug 1, 2025
Maintains: Underperform
Price Target: $15 → $18
Current: $20.36
Upside: -11.59%
Teladoc Health
Jul 25, 2025
Initiates: Neutral
Price Target: $10
Current: $9.46
Upside: +5.71%
Waystar Holding
Jun 30, 2025
Initiates: Outperform
Price Target: $48
Current: $38.97
Upside: +23.17%
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $66.84
Upside: -10.23%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $161.89
Upside: -7.34%
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $13.11
Upside: +37.30%
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $71.44
Upside: +14.78%
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $6.30
Upside: +11.11%
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $96.50
Upside: +30.57%
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $63.84
Upside: +17.48%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.76
Upside: +81.16%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $5.51
Upside: +154.08%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $210.68
Upside: -32.60%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $70.39
Upside: -21.86%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $177.94
Upside: -48.30%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $362.50
Upside: +55.86%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $81.93
Upside: +22.06%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $5.13
Upside: +172.90%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $163.32
Upside: +144.92%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $34.07
Upside: +214.06%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $35.17
Upside: -51.66%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $8.83
Upside: +35.90%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $126.13
Upside: -23.89%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $182.18
Upside: -34.13%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $447.04
Upside: -71.59%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $290.65
Upside: +23.17%